Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

HIV and the Right to Health in Colombia.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Harvard School of Public Health, François-Xavier Bagnoud Center for Health and Human Rights Country of Publication: United States NLM ID: 9502498 Publication Model: Print Cited Medium: Internet ISSN: 2150-4113 (Electronic) Linking ISSN: 10790969 NLM ISO Abbreviation: Health Hum Rights Subsets: MEDLINE
    • Publication Information:
      Original Publication: Boston, MA : Harvard School of Public Health, François-Xavier Bagnoud Center for Health and Human Rights, c1994-
    • Subject Terms:
    • Abstract:
      The first Colombian to claim a judicially enforceable right to health was a gay man living with HIV, who in 1992 claimed a violation of his constitutional rights on account of being denied antiretroviral therapy. Since then, HIV activists have been at the forefront of advancing both the judicialization and social reconstruction of health as a human right. However, their role-and its implications today-has been sometimes overlooked in the study of Colombia's right to health. Based on semi-structured interviews with key stakeholders, we evaluate the HIV movement's effect on the progression of the right to health and resulting health care reform, and analyze the reform's success in addressing the needs of people living with HIV. While the landmark Constitutional Court decision T-760 and resulting health care reform are not the result of any one group, the HIV movement played a significant role in these developments, and its values are largely reflected in the country's new sociopolitical conceptualization of the right to health. However, the movement has faced division over the issue of generic medication availability and among subpopulations who have not been strongly represented or consistent beneficiaries of its successes.
      Competing Interests: Competing interests: None declared.
    • References:
      Health Hum Rights. 2009;11(2):33-45. (PMID: 20845840)
      Biomedica. 2011 Oct-Dec;31(4):532-44. (PMID: 22674364)
      AIDS Care. 2011 Dec;23(12):1602-8. (PMID: 21749222)
      BJOG. 2013 Apr;120(5):652. (PMID: 23480204)
      Health Policy. 2004 May;68(2):129-42. (PMID: 15063014)
      MEDICC Rev. 2011 Jul;13(3):54-7. (PMID: 21778962)
      Int J Infect Dis. 2014 Sep;26:146-8. (PMID: 25080354)
      Mycopathologia. 2013 Feb;175(1-2):91-8. (PMID: 23086383)
      PLoS Med. 2009 Feb 17;6(2):e1000032. (PMID: 19226184)
      Arch Sex Behav. 2014 Nov;43(8):1637-50. (PMID: 24464550)
      Int J Infect Dis. 2010 Apr;14(4):e298-303. (PMID: 19665910)
      Subst Use Misuse. 2016 Jan 28;51(2):230-40. (PMID: 26800352)
      Soc Sci Med. 2015 May;133:36-44. (PMID: 25840048)
      Lancet. 2015 Mar 28;385(9974):1248-59. (PMID: 25458715)
      Rev Salud Publica (Bogota). 2011 Oct;13(5):778-84. (PMID: 22634944)
      Rev Panam Salud Publica. 2011 Jul;30(1):65-73. (PMID: 22159653)
      AIDS. 1997 Aug;11(10):1297-8. (PMID: 9256952)
      Health Aff (Millwood). 2009 May-Jun;28(3):853-63. (PMID: 19414898)
    • Accession Number:
      0 (Drugs, Generic)
    • Publication Date:
      Date Created: 20170601 Date Completed: 20180430 Latest Revision: 20240325
    • Publication Date:
      20240325
    • Accession Number:
      PMC5395009
    • Accession Number:
      28559683